Posts in category Business Standard
Aarti Drugs reports PAT of Rs 47 cr in Q4 FY24 (04-05-2024)
The pharmaceutical company's consolidated net profit declined 15.78% to Rs 47.31 crore in Q4 FY24 as compared with Rs 56.18 crore recorded in Q4 FY23.
Raw Edge Industrial Solutions reports standalone net profit of Rs 0.58 crore in the March 2024 quarter (04-05-2024)
Sales rise 18.30% to Rs 13.12 crore
Avenue Supermarts consolidated net profit rises 22.41% in the March 2024 quarter (04-05-2024)
Sales rise 20.13% to Rs 12726.55 crore
IDBI Bank Q4 PAT climbs 44% to Rs 1,628 cr (04-05-2024)
IDBI Bank announced that its standalone net profit jumped 44% to Rs 1,628 crore in Q4 FY24 as compared with 1,133 crore in Q4 FY23.
Aurobindo Pharma’s Rajasthan-based facility concludes US FDA audit with 9 observations (04-05-2024)
Aurobindo Pharma said that the United States Food and Drug Administration (US FDA) inspected the Unit-II, a formulation manufacturing facility of its wholly owned subsidiary Eugia Pharma Specialities that is situated at Bhiwadi, Rajasthan.
Aurobindo Pharma’s Rajasthan-based facility concludes US FDA audit with 9 observations (04-05-2024)
Aurobindo Pharma said that the United States Food and Drug Administration (US FDA) inspected the Unit-II, a formulation manufacturing facility of its wholly owned subsidiary Eugia Pharma Specialities that is situated at Bhiwadi, Rajasthan.
IDBI Bank consolidated net profit rises 36.83% in the March 2024 quarter (04-05-2024)
Total Operating Income rise 22.08% to Rs 6994.70 crore
IDBI Bank consolidated net profit rises 36.83% in the March 2024 quarter (04-05-2024)
Total Operating Income rise 22.08% to Rs 6994.70 crore
Central Depository Services (India) consolidated net profit rises 104.85% in the March 2024 quarter (04-05-2024)
Sales rise 92.98% to Rs 240.78 crore
Central Depository Services (India) consolidated net profit rises 104.85% in the March 2024 quarter (04-05-2024)
Sales rise 92.98% to Rs 240.78 crore